Long noncoding RNAs (lncRNAs) are aberrantly expressed in various cancers. Although
lncRNA GAS5 (growth arrest-specific transcript 5) has been characterized as a tumor …

Accumulating evidence has shown that the long noncoding RNAs (lncRNAs) play a crucial
role in the regulation of hepatocellular carcinoma (HCC) progression and drug resistance. In …

Background Epithelial ovarian cancer (EOC) is the malignant tumor of the female
reproductive system with the highest fatality rate. Tolerance of chemotherapeutic drugs like …

Long non-coding RNA growth arrest-specific 5 (GAS5) was reported to be aberrantly
expressed in various types of cancers. However, the role of GAS5 in the evolution and …

In recent years, long noncoding RNAs (lncRNAs) have been demonstrated to be important
tumor‐associated regulatory factors. LncRNA growth arrest‐specific transcript 5 (Gas5) acts …

Objective It is already known that long non-coding RNA growth arrest-specific 5 (GAS5) is
downregulated in human colorectal cancer (CRC) cells inhibiting cell proliferation. We …

The growth arrest-specific transcript 5 (GAS5) is a> 200-nt lncRNA molecule that regulates
several cellular functions, including proliferation, apoptosis, invasion and metastasis, across …

Long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has been
revealed to be associated with the progression of various cancers. However, the biological …

Objective Gemcitabine is the first-line drug for chemotherapy of pancreatic cancer. However,
owing to the inherent and acquired resistance, gemcitabine does not change obviously the …

Growth arrest-specific gene 7 (Gas7) was involved in various cellular functions, although its
specific roles and molecular mechanisms in hepatocellular carcinoma (HCC) remained …